March 04, 2015 12:11 AM ET

Capital Markets

Company Overview of BB Biotech Ventures III

Company Overview

Biotech Ventures III specializes in investments in growth capital or earlier-stage technology platform companies. It prefers to invest in biotechnology, pharmaceutical, and medical device companies. It seeks to invest in IP protected technologies with IND enabling technologies with unique IP position. The fund looks for investment opportunities world-wide.

Seestrasse 16

Kuesnacht

Zurich,  CH-8700

Switzerland

Phone:

41 44 267 67 00

Fax:

41 44 267 67 01

Key Executives for BB Biotech Ventures III

Senior Investment Advisor Private Equity
Managing Director and Senior Investment Advisor Private Equity
Age: 43
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Banca Arner SA Europe
Pictet & Cie, Research Division Europe
ZMP Invest AG Europe
Credit Suisse First Boston AG Europe
Naef Gestion Internationale S.A. Europe

Recent Private Companies Transactions

Type
Date
Target
Private Placement
October 30, 2014
Natural Dental Implants AG
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact BB Biotech Ventures III, please visit www.bbbiotechventures.com/en/bb-biotech-ventures/investment-focus/. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.